Addressing the risk and management of cardiometabolic complications in prostate cancer patients on androgen deprivation therapy and androgen receptor axis-targeted therapy: consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology.
Saved in:
| Title: | Addressing the risk and management of cardiometabolic complications in prostate cancer patients on androgen deprivation therapy and androgen receptor axis-targeted therapy: consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology. |
|---|---|
| Authors: | Poon DMC; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.; Comprehensive Oncology Centre, Hong Kong Sanatorium and Hospital, Hong Kong, Hong Kong SAR, China., Tan GM; Division of Cardiology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Chan K; Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong SAR, China., Chan MTY; Division of Urology, Department of Surgery, Tuen Mun Hospital, Hong Kong, Hong Kong SAR, China., Chan TW; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, Hong Kong SAR, China., Kan RWM; eFLO Urology, Hong Kong, Hong Kong SAR, China., Lam MHC; Hong Kong Integrated Oncology Centre, Hong Kong, Hong Kong SAR, China., Leung CLH; Department of Surgery, Kwong Wah Hospital, Hong Kong, Hong Kong SAR, China., Wong KCW; Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Kam KKH; Division of Cardiology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Ng CF; S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Chiu PKF; S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China. |
| Source: | Frontiers in oncology [Front Oncol] 2024 Jan 31; Vol. 14, pp. 1345322. Date of Electronic Publication: 2024 Jan 31 (Print Publication: 2024). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38357197 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Addressing the risk and management of cardiometabolic complications in prostate cancer patients on androgen deprivation therapy and androgen receptor axis-targeted therapy: consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Poon+DMC%22">Poon DMC</searchLink>; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.; Comprehensive Oncology Centre, Hong Kong Sanatorium and Hospital, Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Tan+GM%22">Tan GM</searchLink>; Division of Cardiology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Chan+K%22">Chan K</searchLink>; Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Chan+MTY%22">Chan MTY</searchLink>; Division of Urology, Department of Surgery, Tuen Mun Hospital, Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Chan+TW%22">Chan TW</searchLink>; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Kan+RWM%22">Kan RWM</searchLink>; eFLO Urology, Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Lam+MHC%22">Lam MHC</searchLink>; Hong Kong Integrated Oncology Centre, Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Leung+CLH%22">Leung CLH</searchLink>; Department of Surgery, Kwong Wah Hospital, Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Wong+KCW%22">Wong KCW</searchLink>; Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Kam+KKH%22">Kam KKH</searchLink>; Division of Cardiology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Ng+CF%22">Ng CF</searchLink>; S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Chiu+PKF%22">Chiu PKF</searchLink>; S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2024 Jan 31; Vol. 14, pp. 1345322. <i>Date of Electronic Publication: </i>2024 Jan 31 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38357197 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2024.1345322 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1345322 Titles: – TitleFull: Addressing the risk and management of cardiometabolic complications in prostate cancer patients on androgen deprivation therapy and androgen receptor axis-targeted therapy: consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Poon DMC – PersonEntity: Name: NameFull: Tan GM – PersonEntity: Name: NameFull: Chan K – PersonEntity: Name: NameFull: Chan MTY – PersonEntity: Name: NameFull: Chan TW – PersonEntity: Name: NameFull: Kan RWM – PersonEntity: Name: NameFull: Lam MHC – PersonEntity: Name: NameFull: Leung CLH – PersonEntity: Name: NameFull: Wong KCW – PersonEntity: Name: NameFull: Kam KKH – PersonEntity: Name: NameFull: Ng CF – PersonEntity: Name: NameFull: Chiu PKF IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 01 Text: 2024 Jan 31 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 14 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |
